To investigate the potential therapeutic strategies for c-MET/sgp53 tumors, we developed a stably passaged cell line (MP cells) derived from a c-MET/sgp53 HCC by serial passaging of tumor cells from mouse to mouse (Figs. S9 and S10). Here, MET is linked to neoplasm.